The average price paid by hospitals for cardiac implantable resynchronization pacemakers has dropped 12% over the last year, according to the most recent Modern Healthcare/ECRI Institute Technology ...
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced approval from the U.S. Food and Drug Administration (FDA) for the Allure Quadra ™ ...
MILAN--(BUSINESS WIRE)--Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the launch of REPLY CRT ...
Analysts believe that device makers who are able to launch implantable products whose functioning isn’t hampered by magnetic resonance imaging will win as chronically ill patients are often directed ...
Medtronic announced that it has received FDA approval for its new cardiac resynchronization therapy pacemaker, Viva CRT-P, for patients with HF or atrioventricular block. The device utilizes the ...
Biotronik announced that it has launched the smallest MR conditional cardiac resynchronization therapy pacemaker in the U.S., recently approved by the FDA. According to a press release from the ...
Boston Scientific is recalling Ingenio family of pacemakers (includes models Advantio DR EL, Ingenio DR EL, and Vitalio DR EL) and cardiac resynchronization therapy pacemakers (CRT-Ps) due to the risk ...
DUBLIN., Medtronic plc announced that it has received CE (Conformité Européenne) Mark for a suite of quadripolar cardiac resynchronization therapy pacemakers (CRT-Ps) that also allow patients to ...
ROCHESTER, NY — Some patients with "normalized" LV function when their primary-prevention defibrillating cardiac-resynchronization-therapy device (CRT-D) nears the end of its service life may safely ...
Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the ...
Pacemakers do not result in lower survival than implantable cardiac defibrillator (ICD) devices in patients undergoing cardiac resynchronization therapy (CRT) for heart failure, a large health claims ...
St. Jude ($STJ) thinks it has built a better pacemaker, an ongoing obsession of the medical device giants in pursuit of defending their market turf. The company has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results